Organization
Rheumazentrum Ruhrgebiet, Herne, Germany
21 abstracts
Abstract
A MAJOR CLINICAL RESPONSE TO ANTI-TNF AGENTS IS ASSOCIATED WITH A REDUCED DEVELOPMENT OF FATTY CHANGES IN THE SPINE OF PATIENTS WITH ANKYLOSING SPONDYLITIS – NEW ANALYSES FROM THE EASIC REGISTRY Org: Rheumazentrum Ruhrgebiet, Herne, Germany, German Rheumatism Research Center, Berlin, Germany,
Abstract
ASSOCIATION OF DYSMOBILITY SYNDROME WITH FRACTURE RISK IN THE MROS COHORT Org: Department of Medicine, University of Wisconsin-Madison, Madison, United States, Rheumazentrum Ruhrgebiet, Herne, Germany, California Pacific Medical Center Research Institute, San Francisco, CA, University of California - Davis, Sacramento, University of Minnesota, Minneapolis, United States,
Abstract
ACHIEVEMENT OF A PATIENT ACCEPTABLE SYMPTOM STATE (PASS) AND OF A MINIMUM CLINICALLY IMPORTANT IMPROVEMENT (MCII) WITH ETANERCEPT IN ADVANCED ANKYLOSING SPONDYLITIS: RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (SPINE) Org: Descartes University, Paris, France, Rheumazentrum Ruhrgebiet, Herne, Germany, University of Debrecen, Debrecen, Hungary, Lapeyronie Hospital, Montpellier, Medical Center, Avignon, France,
Abstract
ASAS HEALTH INDEX: VALIDITY AND RELIABILITY IN ARGENTINEAN PATIENTS WITH SPONDYLOARTHRITIS Org: Hospital B. Rivadavia, Buenos Aires, Argentina, Rheumazentrum Ruhrgebiet, Herne, Germany, Hospital la Paz, IdiPaz, Madrid, Spain, Hospital Italiano de Buenos Aires, Instituto de Rehabilitaciόn Psicofísica (IREP), Buenos Aires,
Abstract
ANTI-CD74 IGA ANTIBODIES ARE MOST SENSITIVE AND SPECIFIC TO IDENTIFY YOUNG MALE AXIAL SPONDYLOARTHRITIS PATIENTSOrg: Ghent University Hospital, Rheumatology, Gent, Belgium, VIB, Inflammation Research Center, Gent, Belgium, Medical University Hannover, Immunology and Rheumatology, Hannover, Germany, Rheumazentrum Ruhrgebiet, Herne, Germany,
Abstract
AN IMMEDIATE DECREASE IN SERUM-VEGF-LEVELS HELPS IN PREDICTING A MAJOR RESPONSE IN PATIENTS WITH ANKYLOSING SPONDYLITIS WHO WERE STARTED ON INFLIXIMAB: RESULTS FROM THE ASSERT BIOMARKER STUDY Org: Rheumazentrum Ruhrgebiet, Herne, Germany, University Medical Center, Maastricht, University Medical Center, Amsterdam, Netherlands, Centocor R&D, Inc, New Jersey, United States, University Medical Center, Leiden, Netherlands,
Abstract
A BIOMARKER RESPONSE IS NOT ASSOCIATED WITH LONG-TERM RADIOGRAPHIC PROGRESSION IN AS PATIENTS TREATED WITH INFLIXIMAB: A FOLLOW-UP EVALUATION OF THE ASSERT BIOMARKER STUDY Org: Rheumazentrum Ruhrgebiet, Herne, Germany, University Medical Center, Maastricht, University Medical Center, Amsterdam, University Medical Center, Leiden, Netherlands, German Rheumatism Research Center, Berlin, Germany,
Abstract
ACHIEVING ASDAS-CRP MAJOR IMPROVEMENT AND INACTIVE DISEASE IN PATIENTS WITH ANKYLOSING SPONDYLITIS AFTER TREATMENT WITH GOLIMUMAB IS ASSOCIATED WITH NORMALIZED HEALTH RELATED QUALITY OF LIFE: TWO-YEAR RESULTS FROM THE GO-RAISE TRIAL Org: Leiden Univ Medical Center, Leiden, Netherlands, Oregon Health and Science Univ, Portland, OR, United States, Rheumazentrum Ruhrgebiet, Herne, Germany, Janssen Research & Development, LLC, Spring House, PA, Janssen Global Service, LLC, Malvern, PA, United States,
Abstract
A PROSPECTIVE EVALUATION OF THE DIAGNOSTIC VALUE OF CONVENTIONAL RADIOGRAPHY, ULTRASOUND AND MRI IN COMPARISON TO CLINICAL EXAMINATION FOR THE ASSESSMENT OF HEEL AND KNEE ENTHESITIS IN PATIENTS WITH SPONDYLOARTHRITIS AND CONTROLS Org: Rheumazentrum Ruhrgebiet, Herne, Germany,
Abstract
ACHIEVEMENT OF REMISSION OF INFLAMMATION IN THE SPINE AND SACROILIAC JOINTS MEASURED BY MAGNETIC RESONANCE IMAGING (MRI) IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, AND ASSOCIATIONS BETWEEN MRI AND CLINICAL REMISSION, OVER 96 WEEKS OF TREATMENT WITH CERTOLOrg: Rheumazentrum Ruhrgebiet, Herne, Germany, Department of Medicine, University of Alberta, Alberta, Canada, Academic Medical Center Amsterdam & Atrium Medical Center, Heerlen, Netherlands, Ruhr-University Bochum, Herne, Charité Medical School, Berlin, Germany,
Abstract
ASAS HEALTH INDEX FOR PATIENTS WITH SPONDYLOARTHRITIS: TRANSLATION INTO PORTUGUESE, VALIDATION, AND RELIABILITY Org: CEDOC - NOVA Medical School | Faculdade de Ciências Médicas, NOVA University of Lisbon, Rheumatology Department, Hospital Egas Moniz, Centro Hospitalar de Lisboa Ocidental, Lisbon, Lisbon, Escola Superior de Saúde de Setúbal, Instituto Politecnico de Setúbal, Setúbal, Portugal, Rheumatology, Leiden University Medical Center, Leiden, Netherlands, Hospital Garcia de Orta, Almada,
Abstract
ASSESSMENT OF SPINAL MOBILITY IN AXIAL SPONDYLOARTHRITIS – FIRST VALIDATION STEPS OF A NEW ELECTRONIC QUANTIFICATION TOOL Org: Rheumazentrum Ruhrgebiet, Herne, Germany,
Abstract
Analysis of the different value of magnetic resonance imaging changes in the sacroiliac joints for a diagnosis of axial spondyloarthritis as judged by rheumatologists and radiologistsOrg: Rheumazentrum Ruhrgebiet, Herne, Germany,
Abstract
ASAS RECOMMENDATIONS FOR THE EVALUATION OF NSAID INTAKE IN ANKYLOSING SPONDYLITIS CLINICAL STUDIES/TRIALS Org: Descartes University, Paris, France, Alberta University, Rheumatic Unit Disease, alberta, Canada, Rheumazentrum Ruhrgebiet, Herne, Germany, General Hospital, mexico, Mexico, Charity Campus Benjamin Franklin, Berlin, Berlin, Germany,
Abstract
ADALIMUMAB (HUMIRA®) THERAPY IMPROVES INFLAMMATORY BOWEL DISEASE (IBD) AND PSORIASIS (PS) IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS)Org: Rheumazentrum Ruhrgebiet, Herne, Germany, Ospedale San Carlo di Potenza, Córdoba, Spain, Sismanoglio Hospital, Athens, Greece, Abbott GmbH & Co KG, Ludwigshafen, Germany, Charité – University Medicine Berlin, Berlin, Germany,
Abstract
A RANDOMISED, DOUBLE-BLIND, PARALLEL-GROUP, PHASE 1 STUDY COMPARING THE PHARMACOKINETICS, SAFETY AND EFFICACY OF CT-P13 AND INFLIXIMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 54 WEEK RESULTS FROM THE PLANETAS STUDY Org: Inha Univ. Hospital, Incheon, Korea, Republic Of, Linea Corporis, Warszawa, Wojewodzki Szpital Zespolony w Elblagu, Elbląg, Poland, Institute of Urgent and Recovery Surgery, Donetsk, Ukraine, Univ. Hospital St. Marina, Varna, Bulgaria,
Abstract
ANALYSING IMPAIRMENTS IN PHYSICAL PERFORMANCE (AS ASSESSED BY THE AS PERFORMANCE INDEX (ASPI)) IN PATIENTS WITH AXIAL SPONDYLOARTHRITISOrg: Rheumazentrum Ruhrgebiet, Herne, Germany, Ruhr-University, Bochum, Germany, Leiden University Medical Center (LUMC), Leiden, Netherlands,
Abstract
Association of enthesitis with achievement of normal quality of life and clinical response in patients with non-radiographic axial spondyloarthritis treated with adalimumabOrg: Swedish Medical Center and University of Washington, Seattle, USA, Ghent University, Ghent, Belgium, Rheumazentrum Ruhrgebiet, Herne, Germany, AbbVie, North Chicago, USA,
Abstract
ARE PATIENTS WITH AS WILLING TO PAY FOR TREATMENT WITH INFLIXIMAB? Org: Rheumatology, MUMC, Maastricht, Netherlands, CAPHRI, Maastricht University, Maastricht, Netherlands, Rheumazentrum Ruhrgebiet, Herne, Germany,
Abstract
BASELINE CHARACTERISTICS OF PATIENTS WITH INFLAMMATORY RHEUMATIC MUSCULOSKELETAL DISORDERS: DATA FROM A PROSPECTIVE OBSERVATIONAL COHORT FROM THE GERMAN REGISTRY LOREOrg: Ruhr-Universität Bochum, Bochum, Germany, Rheumazentrum Ruhrgebiet, Herne, Germany,
Abstract
BASELINE DEMOGRAPHIC AND DISEASE-STATE VARIABLES THAT MAY PREDICT A BETTER RESPONSE TO ETANERCEPT IN SUBJECTS WITH ANKYLOSING SPONDYLITIS: ASCEND Org: VU University Medical Center, Amsterdam, Netherlands, Rheumazentrum Ruhrgebiet, Herne, Germany, Pfizer Inc, Collegeville, PA, United States of America,